IP Library Granted Patent US 11,970,733
Granted Patent B2
US 11,970,733 · App. 16/671,979 · Granted Apr 30, 2024

Methods for analyzing nucleic acid sequences

Inventors: Timothy Hsiau (Hayward, CA); Richard Stoner (San Jose, CA); Travis Maures (Pacifica, CA); David Conant (San Francisco, CA)
Assignee: Synthego Corporation
C12Q1/6869C12N9/22C12N15/113C12Q1/6806C12Q1/6853G01N33/48721G06F17/18B01L3/502761B01L2200/10C12N2310/20C12Q2563/116
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,970,733
App. No.
16/671,979
Granted
Apr 30, 2024
Kind
B2
Abstract

The present disclosure provides a method for analyzing nucleic acid sequences. The method can comprise determining, by a computer system, a base trace by trimming a Sanger sequencing trace of a plurality of nucleic acid molecules from a sample based on a first target sequence and a second target sequence. Each of the first and second target sequences can be in the plurality of nucleic acid molecules or can be in the complement of sequence of the plurality of nucleic acid molecules.

Claims (31)

1. A method comprising:

determining, by a computer system, a plurality of predicted sequences of individual nucleic acid molecules in a sample,

wherein the sample has been contacted by at least two different nucleic acid editing tools, and

wherein the determining is based on a Sanger sequencing trace of a plurality of nucleic acid molecules from the sample that has been contacted by the at least two different nucleic acid editing tools;

assessing, by the computer system, an outcome of contacting the sample with the at least two different nucleic acid tools based on determining the plurality of predicted sequences; and

reporting, by the computer system, a predicted knockout sequence to a user.

2. The method of claim 1 , wherein the determining is further based on an additional Sanger sequencing trace of a plurality of nucleic acid molecules from an additional sample not contacted by a nucleic acid editing tool.

3. The method of claim 2 , wherein the determining is further based on at least two different guide sequences of the at least two different nucleic acid editing tools.

4. The method of claim 3 , further comprising determining a base trace by trimming the additional Sanger sequencing trace based on the at least two different guide sequences.

5. The method of claim 4 , wherein the trimming comprises subtracting a portion of the additional Sanger sequencing trace disposed between (i) a predicted cut site operatively coupled to a first guide sequence of the at least two different guide sequences and (ii) an additional predicted cut site operatively coupled to a second guide sequence of the at least two different guide sequences.

6. The method of claim 5 , wherein an individual predicted sequence of the plurality of predicted sequences comprises an insertion or a deletion adjacent to (i) the predicted cut site or (ii) the additional predicted cut site.

7. The method of claim 4 , further comprising identifying a subset of the plurality of predicted sequences by performing a regression analysis.

8. The method of claim 7 , wherein the regression analysis comprises a non-negative least squares regression analysis or a regularized regression analysis.

9. The method of claim 7 , wherein an R-squared value of the regression analysis is at least 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, or 0.95.

10. The method of claim 7 , further comprising reporting to a user a predicted sequence of the subset and a frequency of the predicted sequence in the subset.

11. The method of claim 7 , wherein the regression analysis comprises a Lasso regression analysis.

12. The method of claim 1 , wherein an individual nucleic acid editing tool of the at least two different nucleic acid editing tools comprises a nuclease system.

13. The method of claim 12 , wherein the nuclease system comprises a CRISPR/Cas system.

14. The method of claim 1 , wherein assessing the outcome comprises determining an editing efficiency.

15. A method comprising:

determining, by a computer system, a predicted knockout sequence of a single nucleic acid molecule based on a first Sanger sequencing trace and a second Sanger sequencing trace,

wherein the predicted knockout sequence comprises an indel when compared to the second Sanger sequencing trace; and

reporting, by the computer system, the predicted knockout sequence to a user.

16. The method of claim 15 , wherein the indel of the predicted knockout sequence yields a stop codon.

17. The method of claim 15 , wherein the indel of the predicted knockout sequence is not a multiple of three nucleotides and/or longer than a threshold length.

18. A method comprising:

determining, by a computer system, a first predicted sequence of a single nucleic acid molecule and a second predicted sequence of a single nucleic acid molecule,

wherein the first and second predicted sequences are based on a first Sanger sequencing trace of a first plurality of nucleic acid molecules from a first sample,

wherein the first and second predicted sequences each comprises an indel when compared to a second Sanger sequencing trace of a second plurality of nucleic acid molecules from a second sample, and

wherein the indels of the first and second predicted sequences have a same size and a different nucleic acid sequence; and

reporting, by the computer system, the first predicted sequence and the second predicted sequence to a user.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2025
From: SYNTHEGO CORPORATION
To: EDITCO BIO, INC.
Reel/Frame 069938/0030 →
PATENT SECURITY AGREEMENT Recorded Jan 24, 2022
From: SYNTHEGO CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 058829/0401 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2020
From: HSIAU, TIMOTHY; STONER, RICHARD; MAURES, TRAVIS; CONANT, DAVID
To: SYNTHEGO CORPORATION
Reel/Frame 052025/0671 →
Continuity (3)
Provisional Application 62754451 · Nov 1, 2018
Provisional Application 62754382 · Nov 1, 2018
Related Publication 20200270680A1 · Aug 27, 2020